Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|
| Dir | Wang Xiaodong | 4.58M | $1.56B | - |
| Pres | Wang Lai | 1.45M | $494.04M | - |
| Dir | BAKER BROS. ADVISORS LP | 148.1K | $50.40M | - |
| Dir | HOOPER ANTHONY C | 64.7K | $22.04M | - |
| Dir | Riva Alessandro | 56.9K | $19.38M | - |
Transactions
11 filings · page 18
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|
| 2020-12-29 | Huang Jane | CMO, Hematology | Sale+OE | 800 | $251.64 | $201,308.98 | -47.1% | → |
| 2020-12-14 | Liang Howard | CFO & Chief Strategy Officer | Sale+OE | 91,900 | $229.04 | $21,048,454.15 | -16.4% | → |
| 2020-12-04 | BAKER BROS. ADVISORS LP | Director, 10% Owner | Sell | 1,511,546 | $220.50 | $333,295,893.00 | -11.4% | → |
| 2020-11-30 | Huang Jane | CMO, Hematology | Sale+OE | 1,500 | $267.82 | $401,722.52 | -17.5% | → |
| 2020-10-29 | Huang Jane | CMO, Hematology | Sale+OE | 1,500 | $300.06 | $450,093.01 | -81.6% | → |
| 2020-10-16 | Wang Xiaodong | - | Sell | 5,000 | $320.00 | $1,600,000.00 | -100% | → |
| 2020-10-05 | Wang Xiaodong | - | Sell | 5,000 | $300.00 | $1,500,000.00 | -100% | → |
| 2020-10-05 | Wu Xiaobin | President & GM China | Sell | 4,000 | $300.00 | $1,200,000.00 | -100% | → |
| 2020-10-05 | Liang Howard | CFO & Chief Strategy Officer | Sale+OE | 14,000 | $299.60 | $4,194,413.48 | -15.1% | → |
| 2020-09-29 | Huang Jane | CMO, Hematology | Sale+OE | 1,500 | $280.38 | $420,568.28 | -43.2% | → |
| 2020-09-29 | OYLER JOHN | Chief Executive Officer | Sell | 1,200 | $273.63 | $328,359.02 | -1.8% | → |